Last reviewed · How we verify
Hectorol® injection
At a glance
| Generic name | Hectorol® injection |
|---|---|
| Also known as | Hectorol® |
| Sponsor | Abbott |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection (PHASE4)
- A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis (PHASE4)
- A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hectorol® injection CI brief — competitive landscape report
- Hectorol® injection updates RSS · CI watch RSS
- Abbott portfolio CI